Australian healthcare specialist PainChek (ASX: PCK) is partnering with Ward Medication Management to deliver the federally funded national roll-out of PainChek technology to the Australian Residential Aged Care market.
PainChek has developed a world first smart phone pain assessment and monitoring device, using facial recognition software to accurately assess pain in people who are non-verbal.
PainChek CEO Philip Daffas said Ward MM already has a team of expert Clinical Pharmacists working across residential aged care in Australia.
They are currently delivering medication advisory services to reduce medication related harm within residential aged care.
Mr Daffas said clinical teams from PainChek and Ward Medication Management will team up to deliver training to aged care service providers in the use of the technology as part of the national PainChek roll-out.
“This partnership will help fast track the PainChek Government funded program with WardMM providing their skilled resources to support the PainChek roll out across the more than 2000 aged care homes in Australia” commented Philip Daffas, CEO of PainChek Ltd.
Our joint goal is to deliver the PainChek solution and pain medication training to the nurses and carers who look after the 100,000 Australian aged care residents with dementia within a one-year timeframe” added Mr Daffas.
Ward MM is a leading provider of medication review and quality use of medicines services to the aged and community care sectors. Specialising in geriatric clinical pharmacy, Ward MM provide clinical decision support to doctors and aged care providers. Working alongside, but independently of, supply pharmacies.
Engagement of the residential aged care facilities, marketing of the training program and co- ordination of the sessions will be centralised through PainChek. Ward MM will deliver up to 350 PainChek residential aged care training sessions and Ward MM will also implement a “train the trainer” program co-ordinated via its 30 clinical pharmacists.
Ward MM CEO, Fiona Rhody-Nicoll said there is a great opportunity for the functionality of PainChek to support clinical teams to make better informed decisions, particularly for those who are unable to articulate their pain.
The PainChek technology will allow our own team to translate resident pain-assessment data and insights into actionable medication recommendations for GPs via the Residential Medication Management Review process, delivering a more pro-active and integrated level of care for residents of aged care facilities.”
